#ACTO_Technologies
Majority of Life Sciences Leaders Implement AI Governance Structures to Engage with Emerging Technologies#USA#New_York#AI_Governance#Life_Sciences#ACTO_Technologies
Majority of Life Sciences Leaders Implement AI Governance Structures to Engage with Emerging Technologies
A recent report shows that 64% of life sciences executives are undertaking efforts to establish AI governance, highlighting the industry's readiness to embrace AI technology.
third-news.com
October 29, 2026 at 12:55 PM
ACTO Celebrates Achievement of Veeva Gold Product Partner Status After Nearly Ten Years of Collaborative Success#USA#Toronto#Life_Sciences#ACTO_Technologies#Veeva_Gold
ACTO Celebrates Achievement of Veeva Gold Product Partner Status After Nearly Ten Years of Collaborative Success
ACTO has achieved Veeva Gold Product Partner status, marking a significant milestone in nearly ten years of collaboration aimed at enhancing success for customers in Life Sciences.
third-news.com
September 2, 2026 at 12:51 PM
ACTO Unveils Pioneering Role-Based AI SuperAgents to Transform Life Sciences Field Work#USA#Life_Sciences#ACTO_Technologies#Toronto,_New_York#AI_Superagents
ACTO Unveils Pioneering Role-Based AI SuperAgents to Transform Life Sciences Field Work
ACTO has introduced revolutionary AI-powered SuperAgents tailored for life sciences teams, ensuring efficient, empathetic, and compliant interactions.
third-news.com
April 13, 2026 at 12:59 PM
ACTO Introduces cxZone: Innovative AI Roleplay Tool for Pharma Professionals#USA#Toronto#ACTO_Technologies#AI_Roleplay_Tool#Pharma_Training
ACTO Introduces cxZone: Innovative AI Roleplay Tool for Pharma Professionals
Discover cxZone, the groundbreaking AI-driven roleplay solution designed for pharma field reps, enhancing their training and performance.
third-news.com
July 24, 2025 at 12:40 PM
ACTO Welcomes Former J&J President Lori Tierney to Its Board as a Key Move Towards AI in Life Sciences#USA#New_York#AI_Platform#ACTO_Technologies#Lori_Tierney
ACTO Welcomes Former J&J President Lori Tierney to Its Board as a Key Move Towards AI in Life Sciences
Lori Tierney has been appointed to ACTO's board, bringing over 20 years of experience to enhance the integration of AI in life sciences, driving better patient outcomes.
third-news.com
May 8, 2025 at 11:18 PM